Immediate and Short-Term Intraocular Pressure Changes Following Intravitreal Injection and Associated Factors

医学 眼压 期限(时间) 眼科 量子力学 物理
作者
Manabu Yamamoto,Kumiko Hirayama,Akika Kyo,Gen Kinari,Yuki Kojima,Takeya Kohno,Shigeru Honda
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:14 (14): 4821-4821 被引量:9
标识
DOI:10.3390/jcm14144821
摘要

Objectives: To evaluate the immediate and short-term changes in intraocular pressure (IOP) following intravitreal injection (IVI) of anti-vascular endothelial growth factor (VEGF) agents and to identify the clinical and procedural factors associated with IOP elevation after treatment. Methods: This retrospective study included 118 eyes from 115 patients who underwent IVI with anti-VEGF agents at Osaka Metropolitan University Hospital between September 2024 and January 2025. IOP was measured at three time points, namely before injection, within 1 min after injection, and at 30 min, in selected eyes with a post-injection IOP ≥ 25 mmHg. Differences in IOP elevation were analyzed according to the disease type and anti-VEGF agent. Univariate and multivariate linear regression analyses were performed to identify clinical factors associated with IOP elevation. Results: Mean IOP significantly increased from 13.9 ± 3.3 mmHg at baseline to 39.2 ± 12.4 mmHg immediately after injection (p < 0.001), with 79.7% of eyes showing an IOP ≥ 25 mmHg. Among those remeasured, IOP decreased to 17.7 ± 6.5 mmHg at 30 min. Significant differences in IOP elevation were observed among anti-VEGF agents (p < 0.001), with aflibercept at 2 mg and 8 mg showing greater increases than other agents. Multivariate analysis identified higher baseline IOP, history of glaucoma, absence of prior vitrectomy, and use of aflibercept (2 mg or 8 mg) as significant risk factors for greater post-injection IOP elevation. Conclusions: Transient IOP elevation ≥ 25 mmHg was observed in the majority of eyes after IVI but typically resolved within 30 min. Aflibercept use, high baseline IOP, glaucoma history, and absence of prior vitrectomy were associated with greater IOP elevation. Careful monitoring and attention to injection volume may be warranted, particularly in high-risk patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一木发布了新的文献求助10
1秒前
1秒前
酷波er的应助被美酶桑内采纳,获得10
2秒前
wanci的应助被凪凪采纳,获得10
2秒前
123william发布了新的文献求助10
2秒前
qiangqiangqiang完成签到 ,获得积分10
2秒前
3秒前
鹭江发布了新的文献求助10
4秒前
5秒前
焦一诺发布了新的文献求助10
5秒前
MMP发布了新的文献求助30
5秒前
万能图书馆的应助被Echo采纳,获得40
5秒前
Hong713完成签到,获得积分10
5秒前
脑洞疼的应助被Echo采纳,获得10
6秒前
桐桐的应助被Echo采纳,获得20
6秒前
秋风的应助被Echo采纳,获得10
6秒前
丘比特的应助被Echo采纳,获得10
6秒前
思源的应助被ou采纳,获得10
6秒前
SKY完成签到,获得积分10
6秒前
orange发布了新的文献求助20
7秒前
8秒前
8秒前
8秒前
9秒前
Ding发布了新的文献求助10
10秒前
勤劳的瑀发布了新的文献求助10
10秒前
隐形曼青的应助被薛禾采纳,获得10
10秒前
Dicy发布了新的文献求助10
11秒前
陈1完成签到 ,获得积分10
11秒前
经十路以东的应助被周一采纳,获得10
11秒前
11秒前
清神安完成签到,获得积分10
12秒前
一木完成签到,获得积分10
13秒前
13秒前
13秒前
凪凪发布了新的文献求助10
13秒前
叶子发布了新的文献求助10
14秒前
闻涛完成签到,获得积分20
14秒前
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193925
求助须知:如何正确求助?哪些是违规求助? 9579945
关于积分的说明 21868504
捐赠科研通 7793568
什么是DOI,文献DOI怎么找? 3437462
关于科研通互助平台的介绍 2560923
邀请新用户注册赠送积分活动 2484250